Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

DSM Launches New 3C Technology to Reinvigorate Omega-3 Supplements Category

Posted on: 03 Oct 16

PR Newswire

PARSIPPANY, N.J., Oct. 3, 2016

PARSIPPANY, N.J., Oct. 3, 2016 /PRNewswire/ -- DSM, a global science-based company active in health, nutrition and materials, is launching a new process technology at this year's Supply Side West (SSW) trade show in Las Vegas on October 6th. The unique 3C technology delivers highly-concentrated (up to 85%) and customizable combinations of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) for both pharmaceutical and dietary supplement applications, while providing peace of mind through a consistent supply chain.

DSM 3C Technology is a radically efficient process technology that makes high-concentrate omega-3 EPA + DHA more accessible and relevant to consumers to build a brighter future.  This technology will be a catalyst for category growth by helping to eliminate key barriers to consumption of omega-3 supplements such as capsule size. In addition, it provides brand owners with the versatility to innovate tailored health-focused products to meet consumer needs across a lifetime.

"A large and growing body of evidence shows that insufficient levels of omega-3 EPA + DHA may be associated with serious health complications for many Americans," said Michael McBurney, PhD, FACN, VP of Science, Communications and Advocacy, DSM Nutritional Products.1 Low levels of omega-3 are related to increased risk of cardiovascular disease, which is the leading cause of death among both men and women in the United States.2,3 Currently, 95.7% of Americans are not consuming enough omega-3 EPA + DHA to reach cardioprotective levels.4 

DSM has kicked off the "Modern Movement Forward" marketing campaign to inspire category change through 3C technology.  "This new technology truly makes the oversized pills of traditional fish oil with low EPA & DHA omega 3 content a thing of the past," said Tobe Cohen, Vice President, DSM Nutritional Products. The campaign will be brought to life at the DSM booth, #GG 143 at SSW and through digital & print media. Visitors will learn more about a new line of next generation omega-3, called MEG-3® Ultra produced with 3C Technology.   

Learn More
To learn more about DSM 3C Technology, visit booth# GG 143 and register for the "Technology to Ignite Growth" lunch session on 10/6/16 with special keynote speaker, Kevin Harrington the original Shark on ABC's EMMY-winning hit show Shark Tank. To register for this event, please email Jessica Barreras at

More information can also be found at and

DSM – Bright Science. Brighter Living.™ 
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam.

Or find us on Facebook, Twitter, LinkedIn and YouTube.


  1. Danaei G, Ding E, Ezzati M et al. The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058. doi: 10.1371/journal.pmed.1000058.
  2. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-57.
  3. Mozaffarian D, Benjamin EJ, Go AS et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38-e360. doi: 10.1161/CIR.0000000000000350. 
  4. Murphy RA, Yu EA, Ciappio ED, Mehta S, McBurney MI. Suboptimal Plasma Long Chain n-3 Concentrations are Common among Adults in the United States, NHANES 2003–2004. Nutrients. 2015;7:10282-9. doi : 10.3390/nu/125534.

Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Logo -

To view the original version on PR Newswire, visit:


PR Newswire

Last updated on: 03/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.